Dispute Resolved

Veeva and IQVIA Establish Historic Life Sciences Partnership

Dispute Resolved

Veeva and IQVIA Establish Historic Life Sciences Partnership

主要联络人

Randal Heeb and Matt Hoelle

Veeva and IQVIA Establish Historic Life Sciences Partnership

What happens when two life sciences rivals battle over critical healthcare data?

Veeva Systems Inc. (“Veeva”) and IQVIA, Inc. (“IQVIA”) both provide data, software and solutions to help life sciences companies market and sell life-saving medicines. In 2018, IQVIA sued Veeva for trade secret misappropriation. Veeva countersued for antitrust monopolization claims.

The dispute carried significant implications not only for the parties involved, but also for the broader life sciences industry, as pharmaceutical companies increasingly depend on integrated data and software solutions. The outcome of the dispute had the potential to reshape how customers could access and use critical healthcare data across competing platforms.

FTI Consulting competition expert Dr. Randal Heeb was retained by Veeva to provide expert testimony on the antitrust claims, specifically regarding market definition and harm to competition.

我们的影响力

我们的角色

Brining clarity to complex healthcare technology markets

Dr. Heeb and his team of economists reviewed tens of thousands of documents and datasets that detailed the two companies’ businesses in two data markets and five software markets.

Dr. Heeb submitted three expert reports and provided testimony at the deposition, and his analysis on antitrust liability provided the economic foundation in support of Veeva’s antitrust claims.
The analysis provided statistical evidence that precisely defined the boundaries of the data and software markets in which Veeva and IQVIA compete and the markets in which IQVIA’s alleged anticompetitive conduct occurred.
Dr. Heeb also offered analysis on the trade secret misappropriation claims.

有关团队